首页> Clinical cancer research : an official journal of the American Association for Cancer Research> Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer.

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Adam G,Sowalsky

第一单位： Center for Cancer Research, NCI, NIH, Bethesda, Maryland.

作者： Adam G,Sowalsky ^[1] ; Ines,Figueiredo ^[2] ; Rosina T,Lis ^[1] ; Ilsa,Coleman ^[3] ; Bora,Gurel ^[2] ; Denisa,Bogdan ^[2] ; Wei,Yuan ^[2] ; Joshua W,Russo ^[4] ; John R,Bright ^[1] ; Nichelle C,Whitlock ^[1] ; Shana Y,Trostel ^[1] ; Anson T,Ku ^[1] ; Radhika A,Patel ^[3] ; Lawrence D,True ^[5] ; Jonathan,Welti ^[2] ; Juan M,Jimenez-Vacas ^[2] ; Daniel Nava,Rodrigues ^[2] ; Ruth,Riisnaes ^[2] ; Antje,Neeb ^[2] ; Cynthia T,Sprenger ^[5] ; Amanda,Swain ^[2] ; Scott,Wilkinson ^[1] ; Fatima,Karzai ^[1] ; William L,Dahut ^[1] ; Steven P,Balk ^[4] ; Eva,Corey ^[5] ; Peter S,Nelson ^[6] ; Michael C,Haffner ^[6] ; Stephen R,Plymate ^[7] ; Johann S,de Bono ^[8] ; Adam,Sharp ^[8]

作者单位： Center for Cancer Research, NCI, NIH, Bethesda, Maryland. ^[1] Institute of Cancer Research, London, UK. ^[2] Fred Hutchinson Cancer Research Center, Seattle, Washington. ^[3] Beth Israel Deaconess Medical Center, Boston, Massachusetts. ^[4] University of Washington, Seattle, Washington. ^[5] Fred Hutchinson Cancer Research Center, Seattle, Washington.;University of Washington, Seattle, Washington. ^[6] University of Washington, Seattle, Washington.;Geriatrics Research, Education and Clinical Center, VAPSHCS, Seattle, Washington. ^[7] Institute of Cancer Research, London, UK.;Royal Marsden NHS Foundation Trust, London, UK. ^[8]